
    
      Patients scheduled for elective cataract surgery, will be randomly allocated to receive
      Vigamox 4 times , 1 hour prior to surgery, either via the experimental device in a spray
      form, or via the regular, commercially available bottle.

      Aqueous sample will be collected and submitted to a masked laboratory for measuring Vigamox
      concentration.
    
  